Researchers are zeroing in on the ways SARS-CoV-2 damages and persists inside blood vessels, raising the risk for heart ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

Polypill treatment for cardiovascular disease prevention is of high value in a low-income, underserved population, according ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...

Time-restricted eating, particularly among people with underlying metabolic disorders, may confer benefits beyond weight loss ...

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

The CASE-J trial enrolled 4728 patients, with a mean age of 63.8 years and a mean BMI of 24.6 kg/m 2, who were randomly assigned to either candesartan- or amlodipine-based treatment regimens.

For both reasons, each person’s treatment plan will be different. Read on to learn about the types of MS treatments available. Disease-modifying therapies (DMTs) can reduce the frequency and ...